Mona Hassan Fathelbab

5PUBLICATIONS
18CO-AUTHORS
Innate immunityAutoimmunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 30, 2026
Dysregulation of IL-37/SIGIRR Axis in De Novo acute myeloid leukemia patients: association with treatment response.

|Jun 26, 2025
Berberine mitigates colitis-associated neuroinflammation and anxiety through modulation of the AMPK/NURR1 pathway.

Esraa S Habiba, Mona Hassan Fathelbab, Marwa M AbdElaziz

|Jan 29, 2025
Liraglutide and denatonium benzoate attenuate T2DM-induced metabolic, neurological, and testicular changes in rats: Targeting oxidative stress, inflammation, and BCRP transporter.

Sahar A Harby, Mona Hassan Fathelbab, Basma M Nawwar

|Jan 18, 2024
Doxycycline-Loaded Calcium Phosphate Nanoparticles with a Pectin Coat Can Ameliorate Lipopolysaccharide-Induced Neuroinflammation Via Enhancing AMPK.

Suzan Awad AbdelGhany Morsy, Mona Hassan Fathelbab, Norhan S El-Sayed

|Apr 17, 2023
Implications of BCRP modulation on PTZ-induced seizures in mice: Role of ko143 and metformin as adjuvants to lamotrigine.

Sahar A Harby, Nehal A Khalil, Norhan S El-Sayed

Pageof 1

Frequent Collaborators

3 joint publications

Sahar A Harby

3 joint publications

Norhan S El-Sayed

2 joint publications

Esraa S Habiba

1 joint publications

Nehal A Khalil